The Interleukin-17/Interleukin-22 Innate Axis in the Gut as a New Drug Target in Allergic-Inflammatory and Autoimmune Diseases. A Working Hypothesis

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 14, Iss. 2, 2014-06 ,pp. : 145-151

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting interleukin-21 in inflammatory diseases

By Sarra Massimiliano   Franzèè Eleonora   Pallone Francesco   Monteleone Giovanni  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 6, 2011-06 ,pp. : 695-702

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic potential of interleukin-17 in inflammation and autoimmune diseases

By Yan Jun-Wei   Wang Yu-Jie   Peng Wen-Jia   Tao Jin-Hui   Wan Ya-Nan   Li Bao-Zhu   Mei Bin   Chen Bing   Yao Hua   Yang Guo-Jun   Li Xiang-Pei   Ye Dong-Qing   Wang Jing  

Expert Opinion on Therapeutic Targets, Vol. 18, Iss. 1, 2014-01 ,pp. : 29-41

Informa Healthcare

Access to resources Recommend Favorite

Th22 and related cytokines in inflammatory and autoimmune diseases

By Tian Tian   Yu Shuang   Ma Daoxin  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 2, 2013-02 ,pp. : 113-125

Informa Healthcare

Access to resources Recommend Favorite

Emerging Peptide Therapeutics for Inflammatory Autoimmune Diseases

By  

Current Pharmaceutical Design, Vol. 16, Iss. 9, 2010-03 ,pp. : 1136-1142

Bentham Science Publishers

Access to resources Recommend Favorite